Why the study?
Does delayed electrophysiological testing on amiodarone better predict ventricular tachycardia recurrence in patients with ischemic heart disease?
Does delayed electrophysiological testing on amiodarone better predict ventricular tachycardia recurrence in patients with ischemic heart disease?
Delayed electrophysiological testing after initiating amiodarone more accurately predicts ventricular tachycardia recurrence than early testing.
No takes yet. Share an insight, caveat, or question.
Delayed EP testing may refine VT recurrence risk stratification on amiodarone; leaves open whether it should guide therapy.
Krafchek et al. (1988) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: